- Home
- TNXP vs ATER Comparison
TNXP vs ATER Comparison
Compare TNXP & ATER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNXP
- ATER
- Stock Information
- Founded
- TNXP 2007
- ATER 2014
- Country
- TNXP United States
- ATER United States
- Employees
- TNXP N/A
- ATER N/A
- Industry
- TNXP Biotechnology: Pharmaceutical Preparations
- ATER Home Furnishings
- Sector
- TNXP Health Care
- ATER Consumer Discretionary
- Exchange
- TNXP Nasdaq
- ATER Nasdaq
- Market Cap
- TNXP 19.5M
- ATER 22.8M
- IPO Year
- TNXP N/A
- ATER N/A
- Fundamental
- Price
- TNXP $0.61
- ATER $2.24
- Analyst Decision
- TNXP Strong Buy
- ATER Strong Buy
- Analyst Count
- TNXP 2
- ATER 1
- Target Price
- TNXP $53.50
- ATER N/A
- AVG Volume (30 Days)
- TNXP 202.6M
- ATER 58.4K
- Earning Date
- TNXP 11-12-2024
- ATER 11-11-2024
- Dividend Yield
- TNXP N/A
- ATER N/A
- EPS Growth
- TNXP N/A
- ATER N/A
- EPS
- TNXP N/A
- ATER N/A
- Revenue
- TNXP $11,291,000.00
- ATER $107,193,000.00
- Revenue This Year
- TNXP $64.71
- ATER N/A
- Revenue Next Year
- TNXP $24.49
- ATER $5.47
- P/E Ratio
- TNXP N/A
- ATER N/A
- Revenue Growth
- TNXP 183.05
- ATER N/A
- 52 Week Low
- TNXP $0.12
- ATER $0.23
- 52 Week High
- TNXP $14.08
- ATER $3.95
- Technical
- Relative Strength Index (RSI)
- TNXP 75.02
- ATER 32.99
- Support Level
- TNXP $0.32
- ATER $2.33
- Resistance Level
- TNXP $0.72
- ATER $2.39
- Average True Range (ATR)
- TNXP 0.15
- ATER 0.16
- MACD
- TNXP 0.04
- ATER -0.02
- Stochastic Oscillator
- TNXP 39.61
- ATER 13.25
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
About ATER Aterian Inc.
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operated brands including Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.